Gross Fixed Capital Formation on Specific Environmental Protection Assets in Protection of Biodiversity and Landscape in Manufacture of Basic Pharmaceutical Products and Pharmaceutical Preparations by the Business Sector

This key economic indicator for the Pharmaceutical sector has been recently updated.

  1. France Gross Fixed Capital Formation on Specific Environmental Protection Assets in Protection of Biodiversity and Landscape in Manufacture of Basic Pharmaceutical Products and Pharmaceutical Preparations by the Business Sector rose 8.3% in 2019, compared to a year earlier.
  2. Since 2013 Germany Gross Fixed Capital Formation on Specific Environmental Protection Assets in Protection of Biodiversity and Landscape in Manufacture of Basic Pharmaceutical Products and Pharmaceutical Preparations by the Business Sector fell by 100% year on year attaining €0 Million.

Top Countries in Gross Fixed Capital Formation on Specific Environmental Protection Assets in Protection of Biodiversity and Landscape in Manufacture of Basic Pharmaceutical Products and Pharmaceutical Preparations by the Business Sector

Million Euros - 2013 to 2019

#2 CountriesMillion EurosLastYoY5‑years CAGR
1 #1
France
2.60 2019 +8.3 % NA View data
2 #2
Germany
0.00 2017 NA -100.0 % View data
Showing 1 to 2 of 2 countries

Source: OECD

Go Top